C&EN, February 12, 2018
The author (Guy Villax) presents arguments for an FDA Dean's List as a means to drive the right behaviors in the industry.
FDA is moving in the right direction when it looks to rank quality across pharmaceutical manufacturing sites. However quality is a matter of culture rather than metrics or compliance.
- Read the extended version with links to references, examples and case studies here
- Read the article in Pharmaceutical Technology here